
CANOPY GROWTH CORP
CGCNASDAQTrading Snapshot
- Day Range
- $1.00 β $1.01
- 52-Week Range
- β
- Volume
- $3.53B
- Avg Volume
- $3.34B
- Shares Outstanding
- 449.3M
- Next Earnings
- Sep 13, 2026
Fundamentals Snapshot
- Annual Revenue
- $285M
- Last Q Revenue
- $81M
- P/E Ratio
- β
- P/S Ratio
- 2.2x
- EPS (TTM)
- β
- Dividend Yield
- β
Why Investors Own CGC
- βHigh-growth profile β revenue up +19.9% YoY with expanding US Equity exposure.
- βHealthy economics β 30% gross margin and 16% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
About CANOPY GROWTH CORP
Canopy Growth Corporation (CGC), alongside its affiliated businesses, specializes in the cultivation, marketing, and retail of both cannabis and hemp-derived products. These offerings are designed for both recreational consumption and therapeutic uses, with its primary commercial reach extending across Canada, the United States, and Germany. The company structures its operations into two main divisions: Global Cannabis and a diverse portfolio of Other Consumer Products. Its extensive product range features dried cannabis flower, various extracts and concentrates, infused beverages, edible gummies, and vape cartridges. Canopy Growth distributes these items under numerous well-known brands, such as Tweed, 7ACRES, Martha Stewart CBD, and Spectrum Therapeutics, among others. Originally founded as Tweed Marijuana Inc., the enterprise adopted its current name, Canopy Growth Corporation, in September 2015. Established in 2009, the firm maintains its corporate headquarters in Smiths Falls, Canada.
Otter Score Breakdown
βAnalyst Ratings
βLatest News & Updates

Village Farms Is Undervalued As International Cannabis Revenue Hits Record Levels
Village Farms International's Q2 showed record international cannabis sales, facility expansion, cost cuts & a strong balance sheet. Read more about VFF stock.

Canopy Growth Corporation (WEED:CA) Q1 2027 Earnings Call Transcript
Canopy Growth Corporation (WEED:CA) Q1 2027 Earnings Call August 7, 2026 10:00 AM EDTCompany ParticipantsJohn VincicLuc Mongeau - CEO & DirectorThomas...

Canopy Growth Sees Steady Progress on Profitability Measures
Canopy Growth beats first-quarter estimates as revenue rises 13%, medical cannabis sales increase, and margins improve on MTL Cannabis integration.
Canopy Growth Q1 EPS $(0.02) Beats $(0.04) Estimate, Sales $58.630M Beat $58.520M Estimate
Canopy Growth (NASDAQ:CGC) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0.04) by 50 percent. This is a 87.5 percent increase over losses of $(0.16) per share from the
'THC And CBD From Marijuana Reduces Agitation In 9 Out Of 10 People With Alzheimerβs Or Other Dementia, Study Shows' - Marijuana Moment
https://www.marijuanamoment.net/thc-and-cbd-from-marijuana-reduces-agitation-in-9-out-of-10-people-with-alzheimers-or-other-dementia-study-shows/